@RecoveryDoctor

Professor of Psychiatry & Beh Sciences @StanfordMed decreasing stigma/increasing evidence/improving care. Food tweets. Digital Ed @BMJMentalHealth Opinions mine

 Stanford, CA
Joined January 2013
  • Tweets23K
  • Following1K
  • Followers4.1K
1.8KMedia
Michael Ostacher, MD, MPH retweeted
josh hardman@Josh__HardmanOct 20
Interesting new data on alcohol use in the UK (N=1.7 million). This annual household income trend probably driven by fact that younger generations drink much less. Less than 1 in 50 people aged 18 to 29 drink every day, compared to 1 in 5 people aged over 80!
1
2
283
Michael Ostacher, MD, MPH retweeted
Keith Humphreys
@KeithNHumphreysOct 16
FYI: VA is running a large clinical trial at sites all over the country on GLP-1s for problem drinking. Currently recruiting info in link. va.gov/orlando-health-care/n…

VA launches trial of GLP-1 treatment for alcohol use disorder | VA Orlando health care | Veterans...

The U.S. Department of Veterans Affairs today announced a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use...

va.gov
3
5
15
1,330
Michael Ostacher, MD, MPH retweeted
Seena Fazel@seenafazelOct 14
A month or so away.
Seena Fazel@seenafazelSep 7
Forensic Psychiatry Research Society annual meeting on 16 November (10am-5pm) at Pembroke College, Oxford. New research presentations in morning; risk assessment masterclass in afternoon (focus on methods and systematic reviews) To register and book: eventbrite.co.uk/e/199928154…

Forensic Psychiatry Research Society Meeting & Risk Assessment Masterclass

The annual meeting provides a framework for presenting, appraising, and discussing research proposals and studies within the field.

eventbrite.co.uk
1
1
225
Michael Ostacher, MD, MPH retweeted
T Wolf 🌁
@TwolfrecoveryOct 12
Drug overdose is the #1 cause of death for those age 25-54 in the entire United States. Not just California.
Solve SF
@solve_sfOct 12
Drug overdose was the #1 cause of death in California for those age 25-54 in 2025
6
29
2
104
2,223
Michael Ostacher, MD, MPH retweeted
Boris D Heifets
@TheBorisLabOct 9
Stanford’s neuroanesthesia team is hiring! Great opportunity for an anesthesiologist- we do all kinds of interesting cases, teach residents & students and have ongoing research collabs across the university careers.asahq.org/jobs/view/…

Recent Jobs - American Society of Anesthesiologists

View jobs available on American Society of Anesthesiologists. Search for and apply to open jobs from American Society of Anesthesiologists.

careers.asahq.org
5
10
873
Michael Ostacher, MD, MPH retweeted
Crémieux
@cremieuxrecueilOct 7
Replying to @IterIntellectus
Reminder that this is fake and the study should be retracted.
Crémieux
@cremieuxrecueil11 Mar 2024
This study should be retracted, both for issues the authors can address and issues with the underlying data. Short thread.
17
13
3
618
21,251
Michael Ostacher, MD, MPH retweeted
Chris Aiken, MD@chrisaikenmdOct 6
SAINT (SNT) TMS once promised outsized recovery rates for refractory depression, but two new trials from independent centers bring it back to earth: psych-partners.com/a-setback… Thanks for the find @RecoveryDoctor
9
19
5
76
15,592
Michael Ostacher, MD, MPH retweeted
Stanford University
@StanfordOct 5
The most important briefings of the day. Karl Deisseroth, professor of bioengineering and of psychiatry and behavioral sciences, shares the news of his Nobel Prize with his kids.
530
4,654
935
36,657
4,634,004
Michael Ostacher, MD, MPH retweeted
Nicholas Fabiano, MD
@NTFabianoOct 5
Karl Deisseroth just won the Nobel Prize. He showed that brain cells can be turned on/off by shining blue light on them, after inserting a light-sensitive protein from algae. The method was named optogenetics and has been used worldwide to link specific neural circuits to behavior.
The Nobel Prize
@NobelPrizeOct 5
BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
41
435
36
2,076
68,837
Michael Ostacher, MD, MPH retweeted
Jeffrey Flier
@jflierOct 5
A extremely well deserved Nobel Prize for discoveries that have dramatically changed our ability to study and understand the brain. @NobelPrize
The Nobel Prize
@NobelPrizeOct 5
BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
2
3
24
1,619
Michael Ostacher, MD, MPH retweeted
Nicholas Fabiano, MD
@NTFabianoOct 2
Grit predicts success even after IQ is accounted for. Persistence adds what talent alone does not.
BOSS
@thebeautyofsaasOct 1
mental trick with huge impact no one is better than you. no one is smarter than you. no one can work harder than you. the only reason someone is better than you at something is that they have been doing it for longer. remind yourself of this often, you will turn your life around
51
856
48
7,437
285,489
Michael Ostacher, MD, MPH retweeted
Allen Frances
@AllenFrancesMDSep 30
Serious suggestion to improve psychiatric training & care: All training programs & large scale providers should be required to run a lithium clinic for bipolar disorder & clozapine clinic for schizophrenia. Not having these= neglecting the severely ill/treatment non-responders.
Allen Frances
@AllenFrancesMDSep 29
Lithium & Clozapine stand out as the most effective/least used drugs in psychiatry. Partly because hard to use,but mostly because of poor traimg/poor funding/poor delivery of services.
16
21
1
76
6,327
Michael Ostacher, MD, MPH retweeted
Cycling for Breakfast 🍳@Cycle4BreakfastSep 29
HEY @espn, AN AMERICAN JUST BECAME WORLD CHAMPION. Brandon McNulty, the first American man to do it in 33 years. I checked your feed. Not one post. You’re arguably the biggest sports media brand in the USA. How do you actually miss this?
52
97
7
1,534
62,689
Michael Ostacher, MD, MPH retweeted
Tamar Haspel@TamarHaspelSep 29
New trial of retatrutide (triple agonist, building on GLP-1s), shows 25% weight loss in the highst-dose group. 25%! Just a few years back a trial with 10% weight loss would have been big news. These drugs are the biggest public health boon since antibiotics and vaccines.
NEJM
@NEJMSep 29
In the phase 3 TRIUMPH-1 trial involving patients with obesity, retatrutide, a triple hormone receptor agonist, resulted in substantial weight reduction and a decrease in knee osteoarthritis pain and obstructive sleep apnea events. Full trial results: nej.md/4ycgSHz
A graph from an Original Article published in the New England Journal of Medicine article titled "Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity." The graph shows effect of retatrutide on body weight. The trial name, TRIUMPH-1, is in parentheses after the title. The NEJM identity sits at the bottom.

ALT A graph from an Original Article published in the New England Journal of Medicine article titled "Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity." The graph shows effect of retatrutide on body weight. The trial name, TRIUMPH-1, is in parentheses after the title. The NEJM identity sits at the bottom.

4
7
1
39
4,060
Michael Ostacher, MD, MPH retweeted
Boris D Heifets
@TheBorisLabSep 26
Replying to @RCarhartHarris
@RCarhartHarris your argument seems to be blinding psychedelics is impossible, so stop trying. Set your creativity free! I like the fact that hips can be replaced, hearts fixed, infection cured. How did we get there? Finding causes for psychedelic fx means minimizing bias.
Robin Carhart-Harris
@RCarhartHarrisSep 22
Replying to @TheBorisLab
Not one perfect design but upping aggression on blinding? Why such commitment to a paradigm/procudure over the purpose its intended for (i.e., causal identification)?
1
1
2
9
1,871
Michael Ostacher, MD, MPH retweeted
Jay Bhattacharya, MD, PhD
@NIHDirector_JaySep 25
🔬 Advancing today’s biomedical research to build a healthier tomorrow involves more than publishing research results in journal. It involves verifying those findings through scientific rigor and scrutiny, transforming promising research into discoveries upon which the world can act. To that end, NIH has launched a new reproducibility and replication initiative rooted in one clear conviction—that discovery and independent verification are inseparable pillars of science. Read more in my @ScienceMagazine editorial ➡️ science.org/doi/10.1126/scie…

Verification makes discovery matter

The existing research ecosystem in the United States often treats publication, particularly of new or positive results, as the primary marker of success. To move the scientific enterprise onto a...

science.org
10
38
3
163
10,163
Michael Ostacher, MD, MPH retweeted
Laramie Duncan@LaramieDuncanSep 22
Deeply honored to be awarded a BD2 Discovery Award together with my incredible co-PIs Fernando Goes (@HopkinsMedicine) and Chris Ching (@KeckMedicineUSC ) for our project 'Retrosplenial "Switch Cells" in Bipolar Disorder". Huge thanks to @BD2Discoveries for their support + vision
BD²
@BD2DiscoveriesSep 22
BD² is awarding more than $13M to 3 new Discovery Research teams studying the biology of mood state switching in #BipolarDisorder. 🧠 Teams are led by Laramie Duncan, PhD, Susan Dymecki, MD, PhD, & Akira Sawa, MD, PhD. 🔗 bit.ly/4rrCblZ
Graphic with a blue textured side panel on the left reading "BD² Awards Over $13 Million in Grants to Understand the Mechanisms of Mood State Switching in Bipolar Disorder." Beneath the title, the institutions Harvard Medical School, Johns Hopkins University, and Stanford University are listed. On the right, 11 principal investigators' headshots are pictured. The BD² logo is in the bottom lefthand corner.

ALT Graphic with a blue textured side panel on the left reading "BD² Awards Over $13 Million in Grants to Understand the Mechanisms of Mood State Switching in Bipolar Disorder." Beneath the title, the institutions Harvard Medical School, Johns Hopkins University, and Stanford University are listed. On the right, 11 principal investigators' headshots are pictured. The BD² logo is in the bottom lefthand corner.

5
3
24
1,400
Michael Ostacher, MD, MPH retweeted
Psychedelic Alpha
@Psyched_AlphaSep 14
Our Founder & Editor, Josh Hardman, will speak at The Psychedelic Healthcare Forum, co-hosted by Psychedelic Alpha and Horizons at the New York Academy of Medicine, on October 15th. He will provide a state of the industry before interviewing HHS Deputy General Counsel Matt Zorn on stage. Register today: horizonsconference.org/thurs…
4
24
1,024
Michael Ostacher, MD, MPH retweeted
Stanford Medicine
@StanfordMedSep 9
Congratulations to Stanford Medicine sleep researcher, Emmanuel Mignot, MD, PhD, on receiving this year’s Albert Lasker Basic Medical Research Award, one of the most prestigious science prizes in the world. He discovered that narcolepsy stems from a deficiency of orexin in the brain, opening the door to new sleep therapies. stan.md/4xGWHkT #LaskerAward
Congratulations to Stanford Medicine sleep researcher, Emmanuel Mignot, MD, PhD, on receiving this year’s Albert Lasker Basic Medical Research Award, one of the most prestigious science prizes in the world

ALT Congratulations to Stanford Medicine sleep researcher, Emmanuel Mignot, MD, PhD, on receiving this year’s Albert Lasker Basic Medical Research Award, one of the most prestigious science prizes in the world

5
47
1
179
11,278
Michael Ostacher, MD, MPH retweeted
Kate Knibbs 🏄🏻‍♀️@KnibbsSep 8
anecdote from the canada-us trade war: someone sent me a small thank-you gift for doing a favor worth $10 and i was asked to pay $30 in customs when it arrived 🤪
1
1
11
1,545
Load more